 John Mengshol
Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Galectins | 2 | 2015 | 27 | 0.760 |
Why?
| | Hepatitis C | 2 | 2015 | 257 | 0.630 |
Why?
| | Hepatitis C, Chronic | 3 | 2009 | 153 | 0.540 |
Why?
| | Monocytes | 2 | 2015 | 536 | 0.440 |
Why?
| | Collagenases | 4 | 2001 | 22 | 0.380 |
Why?
| | T-Lymphocytes | 2 | 2010 | 1996 | 0.330 |
Why?
| | Hepacivirus | 2 | 2010 | 244 | 0.330 |
Why?
| | Kupffer Cells | 1 | 2010 | 52 | 0.310 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2010 | 94 | 0.300 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2001 | 287 | 0.300 |
Why?
| | Receptors, Chemokine | 1 | 2009 | 48 | 0.290 |
Why?
| | Interleukin-1 | 3 | 2001 | 961 | 0.280 |
Why?
| | Chemotaxis | 1 | 2009 | 123 | 0.280 |
Why?
| | Dendritic Cells | 1 | 2009 | 499 | 0.220 |
Why?
| | Liver Diseases | 1 | 2007 | 304 | 0.210 |
Why?
| | Antiviral Agents | 1 | 2009 | 772 | 0.190 |
Why?
| | MAP Kinase Signaling System | 2 | 2001 | 306 | 0.180 |
Why?
| | Chondrocytes | 2 | 2001 | 232 | 0.180 |
Why?
| | MAP Kinase Kinase Kinase 1 | 1 | 2001 | 18 | 0.180 |
Why?
| | Matrix Metalloproteinases | 1 | 2002 | 95 | 0.170 |
Why?
| | Hepatocytes | 2 | 2015 | 224 | 0.170 |
Why?
| | Arthritis | 1 | 2002 | 96 | 0.170 |
Why?
| | NF-kappa B | 2 | 2001 | 660 | 0.150 |
Why?
| | Neoplasm Proteins | 1 | 2001 | 441 | 0.140 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 482 | 0.130 |
Why?
| | T-Lymphocyte Subsets | 2 | 2007 | 418 | 0.110 |
Why?
| | Macrophages | 2 | 2015 | 1509 | 0.110 |
Why?
| | Exosomes | 1 | 2015 | 104 | 0.110 |
Why?
| | Toll-Like Receptors | 1 | 2015 | 193 | 0.110 |
Why?
| | Matrix Metalloproteinase 13 | 4 | 2001 | 25 | 0.100 |
Why?
| | Somatostatin | 1 | 2013 | 53 | 0.100 |
Why?
| | Octreotide | 1 | 2013 | 23 | 0.100 |
Why?
| | Cell Communication | 1 | 2015 | 326 | 0.100 |
Why?
| | Transcription Factors | 1 | 2001 | 1733 | 0.100 |
Why?
| | RNA, Messenger | 3 | 2015 | 2820 | 0.090 |
Why?
| | Matrix Metalloproteinase 1 | 3 | 2001 | 22 | 0.090 |
Why?
| | Up-Regulation | 2 | 2007 | 848 | 0.090 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2001 | 153 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2002 | 268 | 0.080 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 11 | 0.080 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 82 | 0.080 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2001 | 265 | 0.080 |
Why?
| | CD4 Antigens | 1 | 2010 | 137 | 0.080 |
Why?
| | Interferon-gamma | 2 | 2010 | 782 | 0.070 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 207 | 0.070 |
Why?
| | Cells, Cultured | 1 | 2015 | 4127 | 0.070 |
Why?
| | Ligands | 1 | 2010 | 667 | 0.070 |
Why?
| | Cell Differentiation | 1 | 2015 | 2045 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2897 | 0.070 |
Why?
| | Critical Care | 1 | 2013 | 703 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 1 | 2010 | 573 | 0.060 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2007 | 185 | 0.060 |
Why?
| | Humans | 12 | 2023 | 145491 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2009 | 1156 | 0.050 |
Why?
| | Immunotherapy | 1 | 2010 | 667 | 0.050 |
Why?
| | Antigens, CD | 1 | 2007 | 557 | 0.050 |
Why?
| | Genotype | 1 | 2009 | 1853 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 1138 | 0.050 |
Why?
| | Occult Blood | 1 | 2023 | 40 | 0.050 |
Why?
| | Tumor Cells, Cultured | 2 | 2001 | 883 | 0.050 |
Why?
| | Core Binding Factor alpha Subunits | 1 | 2001 | 2 | 0.040 |
Why?
| | MAP Kinase Kinase 3 | 1 | 2001 | 6 | 0.040 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2001 | 45 | 0.040 |
Why?
| | Transcription Factor AP-1 | 1 | 2001 | 79 | 0.040 |
Why?
| | Oleanolic Acid | 1 | 2001 | 9 | 0.040 |
Why?
| | Response Elements | 1 | 2001 | 86 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 126 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2007 | 917 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2001 | 276 | 0.040 |
Why?
| | Colonoscopy | 1 | 2023 | 262 | 0.040 |
Why?
| | Base Sequence | 2 | 2001 | 2180 | 0.040 |
Why?
| | Imidazoles | 1 | 2001 | 246 | 0.040 |
Why?
| | Enzyme Induction | 1 | 2000 | 88 | 0.040 |
Why?
| | Disease Progression | 1 | 2007 | 2862 | 0.040 |
Why?
| | Cytokines | 1 | 2007 | 2054 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2001 | 2910 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2001 | 213 | 0.040 |
Why?
| | Protein Structure, Tertiary | 1 | 2001 | 850 | 0.040 |
Why?
| | Apoptosis | 1 | 2007 | 2411 | 0.040 |
Why?
| | Fibroblasts | 2 | 2001 | 1023 | 0.030 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2001 | 431 | 0.030 |
Why?
| | Transfection | 1 | 2000 | 925 | 0.030 |
Why?
| | Pyridines | 1 | 2001 | 607 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2001 | 1247 | 0.030 |
Why?
| | Synovial Membrane | 1 | 1998 | 124 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2001 | 743 | 0.030 |
Why?
| | Middle Aged | 3 | 2023 | 36176 | 0.030 |
Why?
| | Adult | 3 | 2023 | 40707 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2001 | 1487 | 0.030 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 2137 | 0.030 |
Why?
| | Hepatorenal Syndrome | 1 | 2013 | 15 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2009 | 11831 | 0.020 |
Why?
| | Esophageal and Gastric Varices | 1 | 2013 | 36 | 0.020 |
Why?
| | Pleural Effusion | 1 | 2013 | 59 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5891 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2000 | 2594 | 0.020 |
Why?
| | Male | 3 | 2023 | 72817 | 0.020 |
Why?
| | Animals | 3 | 2002 | 38141 | 0.020 |
Why?
| | Mutation | 1 | 2001 | 4093 | 0.020 |
Why?
| | Female | 3 | 2023 | 78763 | 0.020 |
Why?
| | Hypoglycemia | 1 | 2013 | 479 | 0.020 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 1 | 2007 | 14 | 0.020 |
Why?
| | CD57 Antigens | 1 | 2007 | 18 | 0.020 |
Why?
| | Blood | 1 | 2007 | 107 | 0.020 |
Why?
| | Cytomegalovirus | 1 | 2007 | 168 | 0.010 |
Why?
| | Interleukin-2 | 1 | 2007 | 440 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2007 | 376 | 0.010 |
Why?
| | Cytomegalovirus Infections | 1 | 2007 | 206 | 0.010 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2007 | 264 | 0.010 |
Why?
| | B7-H1 Antigen | 1 | 2007 | 243 | 0.010 |
Why?
| | RNA, Nuclear | 1 | 2001 | 5 | 0.010 |
Why?
| | Chondrosarcoma | 1 | 2001 | 17 | 0.010 |
Why?
| | Substrate Specificity | 1 | 2001 | 396 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2007 | 1511 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2007 | 2499 | 0.010 |
Why?
| | Cell Division | 1 | 2001 | 753 | 0.010 |
Why?
| | Collagen | 1 | 2001 | 453 | 0.010 |
Why?
| | Bone Neoplasms | 1 | 2001 | 256 | 0.010 |
Why?
| | Osteoarthritis | 1 | 2001 | 200 | 0.010 |
Why?
| | Liver | 1 | 2007 | 1895 | 0.010 |
Why?
| | Sequence Alignment | 1 | 1998 | 371 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1998 | 535 | 0.010 |
Why?
| | Rabbits | 1 | 1998 | 651 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 2001 | 562 | 0.010 |
Why?
| | Cell Movement | 1 | 2001 | 961 | 0.010 |
Why?
| | Rats | 1 | 1998 | 5581 | 0.000 |
Why?
| | Mice | 1 | 1998 | 18338 | 0.000 |
Why?
|
|
Mengshol's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|